WinMedica is pleased to announce that it is the marketing authorization holder has the exclusive distribution and promotion of products Otocort®, Otilax® & Interbion®

  • Otocort® (Neomycin Sulfate – Dexamethasone – Acetic acid) for the treatment of otitis external
  • Otilax® (Otilonium bromide) for treating spastic conditions and functional dyskinesia of the gastrointestinal system
  • Interbion® (Cefuroxime) to treat infections of the upper and lower respiratory tract, urinary tract, skin and soft tissue
Write a comment:


Your email address will not be published.

2015 © Copyright - WinMedica

Powered by ChannelDoubler